Gael Forterre - Sep 28, 2025 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Signature
/s/ Gael Forterre
Stock symbol
VNRX
Transactions as of
Sep 28, 2025
Transactions value $
-$3,329
Form type
4
Date filed
9/30/2025, 04:01 PM
Previous filing
Aug 19, 2025
Next filing
Oct 7, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Forterre Gael Chief Commercial Officer 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON /s/ Gael Forterre 2025-09-30 0001841637

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNRX Common Stock Tax liability -$3.33K -5.5K -3.31% $0.61 161K Sep 28, 2025 Direct F1
holding VNRX Common Stock 5K Sep 28, 2025 By Spouse
holding VNRX Common Stock 32.5K Sep 28, 2025 By Armorica Partners, LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 13,725 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.
F2 These shares of common stock are managed by Armorica Partners, LLC (formerly Armori Capital Management, LLC) ("Armorica Partners"). Mr. Forterre is the managing director and sole shareholder of Armorica Partners and has voting and dispositive control over the shares held by Armorica Partners. Mr. Forterre disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.